Sentinus, LLC Clear Point Neuro, Inc. Transaction History

Sentinus, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$6.03 - $7.86 $1.13 Million - $1.47 Million	-186,620 Reduced 92.57%	14,970 $101,000
Q2 2023 Aug 14, 2023	BUY	$6.54 - $10.58 $327,327 - $529,529	50,050 Added 33.03%	201,590 $1.46 Million
Q1 2023 May 15, 2023	BUY	$7.33 - $10.63 $401,610 - $582,417	54,790 Added 56.63%	151,540 $1.28 Million
Q4 2022 Feb 15, 2023	BUY	$7.7 - $11.21 $475,090 - $691,657	61,700 Added 176.03%	96,750 $819,000
Q3 2022 Nov 16, 2022	BUY	$9.82 - $16.49 $344,191 - $577,974	35,050 New	35,050 $363,000

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $400M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Sentinus, LLC, based on Form 13F filings with the SEC.

Stay updated on Sentinus, LLC with notifications on news.